Financials

  • Market Capitalization 3.24 B
  • Employee 354
  • Founded 2016
  • CEO Frank Watanabe
  • Website www.arcutis.com
  • Headquarter Delaware, United States
  • FIGI BBG00QN8K4M4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-223.38
Rapporto prezzo/fatturato
9.82

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1581
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
18.80 USD-3.14%-6.37%-32.88%-4.95%3.24 B USD
1586
VKTX
Viking Therapeutics, Inc. - Common Stock
27.84 USD-1.76%-4.03%-12.18%-15.28%3.25 B USD
1592
LEGN
Legend Biotech Corporation - American Depositary Shares
18.15 USD+1.97%-3.61%-3.46%-43.25%3.36 B USD
1600
TARS
Tarsus Pharmaceuticals, Inc. - Common Stock
73.33 USD-1.44%-1.25%-7.98%+11.01%3.22 B USD

Notizie